NASDAQ: CTSO       Cytosorbents Cor
Last Price Today's Change   Day's Range   Trading Volume
9.58   +0.29 (3.12%)  9.12 - 9.67  279,400


Avg Volume (4 weeks):350,005
4 Weeks Range:7.91 - 9.67
4 Weeks Price Volatility (%):
52 Weeks Range:3.60 - 11.74
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

CytoSorbents Corp is a critical care immunotherapy company. It investigates and commercializes its blood purification technology to reduce uncontrolled inflammation in hospitalized patients internationally with the goal of preventing and treating multiple organ failure in life-threatening illnesses and cardiac surgery. Its product portfolio consists of Cytosord, Contrastsorb, Vetresq, Hemodefend and Drugsorb. The company's intellectual property consists of composition of matter, materials, methods of production, systems incorporating the technology and multiple medical uses. It derives its revenue from product sales and grants.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

6239  2800  512  101 

Top 10 Active Counters
 AMC 3.51+0.60 
 CTRM 0.405-0.008 
 ADMP 1.79-0.54 
 GME 65.01+22.42 
 SNDL 0.645+0.003 
 AZRX 1.84+0.62 
 PLTR 32.58+6.73 
 SENS 2.31+0.08 
 MKD 1.53+0.64 
 NIO 61.95+3.00